StonvexLoading…
StonvexStonvexStonvexCore line items from LOB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $149.41M | $233.86M | $908.47M | $668.82M | $437.39M |
Operating Income | Not available | $40.08M | $142.81M | $80.91M | $44.33M |
Net Income | Not available | $30.04M | $105.87M | $59.66M | $33.15M |
EPS (Diluted) | $0.64 | $0.60 | $2.23 | $1.28 | $0.72 |
Total Assets | Not available | $15.30B | $15.13B | $14.67B | $13.83B |
Total Liabilities | Not available | $14.02B | $13.88B | $13.46B | $12.76B |
Cash & Equivalents | Not available | $816.13M | $864.90M | $892.45M | $662.75M |
Free Cash Flow OCF − CapEx | Not available | $85.34M | $143.49M | $73.10M | $12.54M |
Shares Outstanding | Not available | 46.51M | 46.04M | 45.96M | 45.83M |